Waters (WAT) | Financial Analysis & Statements
Waters Corporation Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
932.4M
Gross Profit
569.5M
61.08%
Operating Income
270.5M
29.01%
Net Income
225.2M
24.16%
EPS (Diluted)
$3.77
Balance Sheet Metrics
Total Assets
5.1B
Total Liabilities
2.5B
Shareholders Equity
2.6B
Debt to Equity
0.98
Cash Flow Metrics
Operating Cash Flow
167.0M
Free Cash Flow
125.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Waters Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.2B | 3.0B | 3.0B | 3.0B | 2.8B |
| Cost of Goods Sold | 1.3B | 1.2B | 1.2B | 1.2B | 1.2B |
| Gross Profit | 1.9B | 1.8B | 1.8B | 1.7B | 1.6B |
| Gross Margin % | 59.3% | 59.4% | 59.6% | 58.0% | 58.5% |
| Operating Expenses | |||||
| Research & Development | 195.7M | 183.0M | 174.9M | 176.2M | 168.4M |
| Selling, General & Administrative | 830.4M | 690.1M | 736.0M | 658.0M | 627.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.0B | 873.2M | 911.0M | 834.2M | 795.3M |
| Operating Income | 802.6M | 837.9M | 817.7M | 883.2M | 826.9M |
| Operating Margin % | 25.4% | 28.3% | 27.7% | 29.7% | 29.7% |
| Non-Operating Items | |||||
| Interest Income | 18.8M | 17.4M | 16.6M | 11.0M | 12.2M |
| Interest Expense | 69.5M | 89.7M | 98.9M | 48.8M | 44.9M |
| Other Non-Operating Income | 3.1M | -10.8M | 807.0K | -7.6M | 12.0M |
| Pre-tax Income | 754.9M | 754.9M | 736.2M | 837.8M | 806.2M |
| Income Tax | 112.2M | 117.0M | 94.0M | 130.1M | 113.4M |
| Effective Tax Rate % | 14.9% | 15.5% | 12.8% | 15.5% | 14.1% |
| Net Income | 642.6M | 637.8M | 642.2M | 707.8M | 692.8M |
| Net Margin % | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% |
| Key Metrics | |||||
| EBITDA | 1.0B | 1.0B | 1.0B | 1.0B | 988.0M |
| EPS (Basic) | $10.80 | $10.75 | $10.87 | $11.80 | $11.25 |
| EPS (Diluted) | $10.76 | $10.71 | $10.84 | $11.73 | $11.17 |
| Basic Shares Outstanding | 59509000 | 59333000 | 59076000 | 59985000 | 61575000 |
| Diluted Shares Outstanding | 59509000 | 59333000 | 59076000 | 59985000 | 61575000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Waters Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 587.8M | 324.4M | 395.1M | 480.5M | 501.2M |
| Short-term Investments | - | 934.0K | 898.0K | 862.0K | 68.1M |
| Accounts Receivable | 828.8M | 733.4M | 702.2M | 722.9M | 612.6M |
| Inventory | 572.4M | 477.3M | 516.2M | 455.7M | 356.1M |
| Other Current Assets | 158.6M | 133.1M | 138.5M | 103.9M | 90.9M |
| Total Current Assets | 2.1B | 1.7B | 1.8B | 1.8B | 1.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 824.5M | 753.4M | 749.3M | 641.5M | 622.5M |
| Goodwill | 3.2B | 3.2B | 3.2B | 1.1B | 1.1B |
| Intangible Assets | 558.2M | 567.9M | 629.2M | 227.4M | 242.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 307.8M | 295.7M | 215.7M | 191.1M | 153.1M |
| Total Non-Current Assets | 2.9B | 2.9B | 2.9B | 1.5B | 1.5B |
| Total Assets | 5.1B | 4.6B | 4.6B | 3.3B | 3.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 103.8M | 99.9M | 84.7M | 93.3M | 96.8M |
| Short-term Debt | 491.1M | 25.5M | 77.8M | 76.4M | 27.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 230.6M | 149.3M | 168.7M | 140.3M | 155.1M |
| Total Current Liabilities | 1.2B | 789.8M | 789.6M | 785.7M | 680.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1,000.0M | 1.7B | 2.4B | 1.6B | 1.6B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 197.8M | 183.8M | 137.8M | 117.5M | 89.8M |
| Total Non-Current Liabilities | 1.3B | 1.9B | 2.7B | 2.0B | 2.0B |
| Total Liabilities | 2.5B | 2.7B | 3.5B | 2.8B | 2.7B |
| Equity | |||||
| Common Stock | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M |
| Retained Earnings | 10.4B | 9.8B | 9.2B | 8.5B | 7.8B |
| Treasury Stock | 10.2B | 10.1B | 10.1B | 10.1B | 9.4B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.6B | 1.8B | 1.2B | 504.5M | 367.6M |
| Key Metrics | |||||
| Total Debt | 1.5B | 1.7B | 2.4B | 1.7B | 1.6B |
| Working Capital | 908.1M | 879.4M | 963.3M | 978.2M | 948.4M |
Balance Sheet Composition
Waters Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 642.6M | 637.8M | 642.2M | 707.8M | 692.8M |
| Depreciation & Amortization | 206.2M | 191.8M | 165.9M | 130.4M | 131.7M |
| Stock-Based Compensation | 54.1M | 44.7M | 36.9M | 42.6M | 29.9M |
| Working Capital Changes | -233.4M | -111.4M | -240.3M | -247.1M | -114.1M |
| Operating Cash Flow | 652.6M | 762.1M | 603.6M | 611.7M | 757.0M |
| Investing Activities | |||||
| Capital Expenditures | -112.7M | -142.5M | -160.6M | -175.9M | -161.3M |
| Acquisitions | -7.3M | -1.5M | 742.0K | 8.9M | -1.8M |
| Investment Purchases | 0 | -3.7M | -1.8M | -11.4M | -279.7M |
| Investment Sales | 0 | 3.7M | 1.8M | 78.0M | 218.1M |
| Investing Cash Flow | -152.3M | -144.0M | -1.4B | -100.4M | -224.6M |
| Financing Activities | |||||
| Share Repurchases | -14.7M | -13.5M | -70.3M | -626.1M | -648.9M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 70.0M | 170.0M | 1.5B | 205.0M | 510.0M |
| Debt Repayment | -290.0M | -900.0M | -670.0M | -145.0M | -350.0M |
| Financing Cash Flow | -258.0M | -727.0M | 725.2M | -552.4M | -493.9M |
| Free Cash Flow | 539.8M | 619.6M | 442.2M | 428.2M | 579.0M |
| Net Change in Cash | 242.3M | -108.9M | -113.6M | -41.2M | 38.4M |
Cash Flow Trend
Waters Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
28.90
Forward P/E
19.04
Price to Book
7.24
Price to Sales
9.65
PEG Ratio
-9.39
Profitability Ratios
Profit Margin
20.30%
Operating Margin
33.76%
Return on Equity
29.28%
Return on Assets
11.52%
Financial Health
Current Ratio
1.73
Debt to Equity
60.28
Beta
1.20
Per Share Data
EPS (TTM)
$10.77
Book Value per Share
$43.01
Revenue per Share
$53.19
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| WAT | 30.5B | 28.90 | 7.24 | 29.28% | 20.30% | 60.28 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Idexx Laboratories | 44.7B | 42.92 | 27.85 | 66.20% | 24.62% | 60.83 |
| Agilent Technologies | 32.7B | 25.67 | 4.76 | 19.95% | 18.26% | 51.39 |
| Natera | 27.4B | - | 15.75 | -14.32% | -9.03% | 12.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






